{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "CitationSubset": ["IM"], "OtherAbstract": [], "KeywordList": [["Merkel cell carcinoma", "basal cell carcinoma", "p40", "p63", "skin cancer", "squamous cell carcinoma"]], "GeneralNote": [], "OtherID": [], "InvestigatorList": [], "PMID": "31744230", "DateCompleted": {"Year": "2020", "Month": "04", "Day": "21"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "11", "Day": "17"}], "Language": ["eng"], "ELocationID": ["5781", "10.3390/ijms20225781"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "20", "Issue": "22", "PubDate": {"Year": "2019", "Month": "Nov", "Day": "17"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer.", "Abstract": {"AbstractText": ["Skin cancer is the most common type of cancer worldwide. Ozone depletion and climate changes might cause a further increase in the incidence rate in the future. Although the early detection of skin cancer enables it to be treated successfully, some tumours can evolve and become more aggressive, especially in the case of melanoma. Therefore, good diagnostic and prognostic markers are needed to ensure correct detection and treatment. Transcription factor p63, a member of the p53 family of proteins, plays an essential role in the development of stratified epithelia such as skin. In this paper, we conduct a comprehensive review of p63 expression in different types of skin cancer and discuss its possible use in the diagnosis and prognosis of cutaneous tumours."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental Medicine, TOR, University of Rome \"Tor Vergata\", 00133 Rome, Italy."}], "Identifier": ["0000-0002-1575-8725"], "LastName": "Smirnov", "ForeName": "Artem", "Initials": "A"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental Medicine, TOR, University of Rome \"Tor Vergata\", 00133 Rome, Italy."}], "Identifier": ["0000-0002-3711-2714"], "LastName": "Anemona", "ForeName": "Lucia", "Initials": "L"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental Medicine, TOR, University of Rome \"Tor Vergata\", 00133 Rome, Italy."}], "Identifier": ["0000-0002-3746-7478"], "LastName": "Novelli", "ForeName": "Flavia", "Initials": "F"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental Medicine, TOR, University of Rome \"Tor Vergata\", 00133 Rome, Italy."}], "Identifier": ["0000-0003-3004-367X"], "LastName": "Piro", "ForeName": "Cristina M", "Initials": "CM"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Istituto Dermopatico dell'Immacolata-IRCCS, 00163 Rome, Italy."}], "Identifier": ["0000-0002-4717-4740"], "LastName": "Annicchiarico-Petruzzelli", "ForeName": "Margherita", "Initials": "M"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental Medicine, TOR, University of Rome \"Tor Vergata\", 00133 Rome, Italy."}, {"Identifier": [], "Affiliation": "MRC-Toxicology Unit, University of Cambridge, Cambridge CB2 1QP, UK."}], "Identifier": [], "LastName": "Melino", "ForeName": "Gerry", "Initials": "G"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental Medicine, TOR, University of Rome \"Tor Vergata\", 00133 Rome, Italy."}, {"Identifier": [], "Affiliation": "Istituto Dermopatico dell'Immacolata-IRCCS, 00163 Rome, Italy."}], "Identifier": [], "LastName": "Candi", "ForeName": "Eleonora", "Initials": "E"}], "GrantList": [{"GrantID": "MC_U132670600", "Acronym": "MRC_", "Agency": "Medical Research Council", "Country": "United Kingdom"}, {"GrantID": "MC_UU_00025/2", "Acronym": "MRC_", "Agency": "Medical Research Council", "Country": "United Kingdom"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers, Tumor"}, {"RegistryNumber": "0", "NameOfSubstance": "TP63 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Suppressor Proteins"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Biomarkers, Tumor"}, {"QualifierName": ["diagnosis", "metabolism"], "DescriptorName": "Carcinoma, Basal Cell"}, {"QualifierName": ["diagnosis", "metabolism"], "DescriptorName": "Carcinoma, Squamous Cell"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Immunohistochemistry"}, {"QualifierName": ["diagnosis", "metabolism"], "DescriptorName": "Melanoma"}, {"QualifierName": [], "DescriptorName": "Prognosis"}, {"QualifierName": ["diagnosis", "metabolism"], "DescriptorName": "Skin Neoplasms"}, {"QualifierName": ["metabolism"], "DescriptorName": "Transcription Factors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Suppressor Proteins"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Valent A., Minty A., Chalon P., Lelias J.M., Dumont X., et al. Monoallelically Expressed Gene Related to P53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers. Cell. 1997;90:809\u2013819. doi: 10.1016/S0092-8674(00)80540-1.", "ArticleIdList": ["10.1016/S0092-8674(00)80540-1", "9288759"]}, {"Citation": "Levine A.J., Oren M. The First 30 Years of P53: Growing Ever More Complex. Nat. Rev. Cancer. 2009;9:749. doi: 10.1038/nrc2723.", "ArticleIdList": ["10.1038/nrc2723", "PMC2771725", "19776744"]}, {"Citation": "Melino G., Lu X., Gasco M., Crook T., Knight R.A. Functional Regulation of P73 and P63: Development and Cancer. Trends Biochem. Sci. 2003;28:663\u2013670. doi: 10.1016/j.tibs.2003.10.004.", "ArticleIdList": ["10.1016/j.tibs.2003.10.004", "14659698"]}, {"Citation": "Yang A., Kaghad M., Wang Y., Gillett E., Fleming M.D., D\u00f6tsch V., Andrews N.C., Caput D., McKeon F. P63, a P53 Homolog at 3Q27\u201329, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities. Mol. Cell. 1998;2:305\u2013316. doi: 10.1016/S1097-2765(00)80275-0.", "ArticleIdList": ["10.1016/S1097-2765(00)80275-0", "9774969"]}, {"Citation": "Donehower L.A. The P53-Deficient Mouse: A Model for Basic and Applied Cancer Studies. Semin. Cancer Biol. 1996;7:269\u2013278. doi: 10.1006/scbi.1996.0035.", "ArticleIdList": ["10.1006/scbi.1996.0035", "9110404"]}, {"Citation": "Yang A., Schweitzer R., Sun D., Kaghad M., Walker N., Bronson R.T., Tabin C., Sharpe A., Caput D., Crum C., et al. P63 Is Essential for Regenerative Proliferation in Limb, Craniofacial and Epithelial Development. Nature. 1999;398:714\u2013718. doi: 10.1038/19539.", "ArticleIdList": ["10.1038/19539", "10227294"]}, {"Citation": "Yang A., Walker N., Bronson R., Kaghad M., Oosterwegel M., Bonnin J., Vagner C., Bonnet H., Dikkes P., Sharpe A., et al. P73-Deficient Mice Have Neurological, Pheromonal and Inflammatory Defects but Lack Spontaneous Tumours. Nature. 2000;404:99. doi: 10.1038/35003607.", "ArticleIdList": ["10.1038/35003607", "10716451"]}, {"Citation": "Petitjean A., Ruptier C., Tribollet V., Hautefeuille A., Chardon F., Cavard C., Puisieux A., Hainaut P., De Fromentel C.C. Properties of the Six Isoforms of P63: P53-like Regulation in Response to Genotoxic Stress and Cross Talk with \u0394Np73. Carcinogenesis. 2008;29:273\u2013281. doi: 10.1093/carcin/bgm258.", "ArticleIdList": ["10.1093/carcin/bgm258", "18048390"]}, {"Citation": "Duijf P.H.G. Gain-of-Function Mutation in ADULT Syndrome Reveals the Presence of a Second Transactivation Domain in P63. Hum. Mol. Genet. 2002;11:799\u2013804. doi: 10.1093/hmg/11.7.799.", "ArticleIdList": ["10.1093/hmg/11.7.799", "11929852"]}, {"Citation": "Yang A., McKeon F. P63 and P73: P53 Mimics, Menaces and More. Nat. Rev. Mol. Cell Biol. 2000;1:199. doi: 10.1038/35043127.", "ArticleIdList": ["10.1038/35043127", "11252895"]}, {"Citation": "McGrath J.A. Hay-Wells Syndrome Is Caused by Heterozygous Missense Mutations in the SAM Domain of P63. Hum. Mol. Genet. 2001;10:221\u2013229. doi: 10.1093/hmg/10.3.221.", "ArticleIdList": ["10.1093/hmg/10.3.221", "11159940"]}, {"Citation": "Der Ou H., L\u00f6hr F., Vogel V., M\u00e4ntele W., D\u00f6tsch V. Structural Evolution of C-Terminal Domains in the P53 Family. EMBO J. 2007;26:3463\u20133473.", "ArticleIdList": ["PMC1933395", "17581633"]}, {"Citation": "Serber Z., Lai H.C., Yang A., Ou H.D., Sigal M.S., Kelly A.E., Darimont B.D., Duijf P.H.G., van Bokhoven H., McKeon F., et al. A C-Terminal Inhibitory Domain Controls the Activity of P63 by an Intramolecular Mechanism. Mol. Cell. Biol. 2002;22:8601\u20138611. doi: 10.1128/MCB.22.24.8601-8611.2002.", "ArticleIdList": ["10.1128/MCB.22.24.8601-8611.2002", "PMC139862", "12446779"]}, {"Citation": "Straub W.E., Weber T.A., Sch\u00e4fer B., Candi E., Durst F., Ou H.D., Rajalingam K., Melino G., D\u00f6tsch V. The C-Terminus of P63 Contains Multiple Regulatory Elements with Different Functions. Cell Death Dis. 2010;1:e5. doi: 10.1038/cddis.2009.1.", "ArticleIdList": ["10.1038/cddis.2009.1", "PMC3032508", "21364624"]}, {"Citation": "Tuppi M., Kehrloesser S., Coutandin D.W., Rossi V., Luh L.M., Strubel A., H\u00f6tte K., Hoffmeister M., Sch\u00e4fer B., De Oliveira T., et al. Oocyte DNA Damage Quality Control Requires Consecutive Interplay of CHK2 and CK1 to Activate P63. Nat. Struct. Mol. Biol. 2018;25:261. doi: 10.1038/s41594-018-0035-7.", "ArticleIdList": ["10.1038/s41594-018-0035-7", "29483652"]}, {"Citation": "Crum C.P., McKeon F.D. P63 in Epithelial Survival, Germ Cell Surveillance, and Neoplasia. Annu. Rev. Pathol. Mech. Dis. 2010;5:349\u2013371. doi: 10.1146/annurev-pathol-121808-102117.", "ArticleIdList": ["10.1146/annurev-pathol-121808-102117", "20078223"]}, {"Citation": "Candi E., Rufini A., Terrinoni A., Giamboi-Miraglia A., Lena A.M., Mantovani R., Knight R., Melino G. \u0394Np63 Regulates Thymic Development through Enhanced Expression of FgfR2 and Jag2. Proc. Natl. Acad. Sci. USA. 2007;104:11999\u201312004. doi: 10.1073/pnas.0703458104.", "ArticleIdList": ["10.1073/pnas.0703458104", "PMC1924561", "17626181"]}, {"Citation": "Candi E., Cipollone R., Di Val Cervo P.R., Gonfloni S., Melino G., Knight R. P63 in Epithelial Development. Cell. Mol. Life Sci. 2008;65:3126. doi: 10.1007/s00018-008-8119-x.", "ArticleIdList": ["10.1007/s00018-008-8119-x", "PMC11131713", "18560758"]}, {"Citation": "Candi E., Rufini A., Terrinoni A., Dinsdale D., Ranalli M., Paradisi A., De Laurenzi V., Spagnoli L.G., Catani M.V., Ramadan S., et al. Differential Roles of P63 Isoforms in Epidermal Development: Selective Genetic Complementation in P63 Null Mice. Cell Death Differ. 2006;13:1037. doi: 10.1038/sj.cdd.4401926.", "ArticleIdList": ["10.1038/sj.cdd.4401926", "16601749"]}, {"Citation": "Romano R.-A., Smalley K., Magraw C., Serna V.A., Kurita T., Raghavan S., Sinha S. \u0394Np63 Knockout Mice Reveal Its Indispensable Role as a Master Regulator of Epithelial Development and Differentiation. J. Cell Sci. 2012;139:772\u2013782.", "ArticleIdList": ["PMC3265062", "22274697"]}, {"Citation": "Vanbokhoven H., Melino G., Candi E., Declercq W. P63, a Story of Mice and Men. J. Investig. Dermatol. 2011;131:1196\u20131207. doi: 10.1038/jid.2011.84.", "ArticleIdList": ["10.1038/jid.2011.84", "21471985"]}, {"Citation": "Rufini A., Weil M., McKeon F., Barlattani A., Melino G., Candi E. P63 Protein Is Essential for the Embryonic Development of Vibrissae and Teeth. Biochem. Biophys. Res. Commun. 2006;340:737\u2013741. doi: 10.1016/j.bbrc.2005.12.065.", "ArticleIdList": ["10.1016/j.bbrc.2005.12.065", "16410075"]}, {"Citation": "Di Como C.J., Urist M.J., Babayan I., Drobnjak M., Hedvat C.V., Teruya-Feldstein J., Pohar K., Hoos A., Cordon-Cardo C. P63 Expression Profiles in Human Normal and Tumor Tissues. Clin. Cancer Res. 2002;8:494\u2013501.", "ArticleIdList": ["11839669"]}, {"Citation": "Tsujita-Kyutoku M., Kiuchi K., Danbara N., Yuri T., Senzaki H., Tsubura A. P63 Expression in Normal Human Epidermis and Epidermal Appendages and Their Tumors. J. Cutan. Pathol. 2003;30:11\u201317. doi: 10.1034/j.1600-0560.2003.300102.x.", "ArticleIdList": ["10.1034/j.1600-0560.2003.300102.x", "12534798"]}, {"Citation": "Reis-Filho J.S., Torio B., Albergaria A., Schmitt F.C. P63 Expression in Normal Skin and Usual Cutaneous Carcinomas. J. Cutan. Pathol. 2002;29:517\u2013523. doi: 10.1034/j.1600-0560.2002.290902.x.", "ArticleIdList": ["10.1034/j.1600-0560.2002.290902.x", "12358808"]}, {"Citation": "Matin R.N., Chikh A., Law Pak Chong S., Mesher D., Graf M., Sanza P., Senatore V., Scatolini M., Moretti F., Leigh I.M., et al. P63 Is an Alternative P53 Repressor in Melanoma That Confers Chemoresistance and a Poor Prognosis. J. Exp. Med. 2013;210:581\u2013603. doi: 10.1084/jem.20121439.", "ArticleIdList": ["10.1084/jem.20121439", "PMC3600906", "23420876"]}, {"Citation": "ENCODE Project Consortium An Integrated Encyclopedia of DNA Elements in the Human Genome. Nature. 2012;489:57\u201374. doi: 10.1038/nature11247.", "ArticleIdList": ["10.1038/nature11247", "PMC3439153", "22955616"]}, {"Citation": "Dohata A., Chambers J.K., Uchida K., Nakazono S., Kinoshita Y., Nibe K., Nakayama H. Clinical and Pathologic Study of Feline Merkel Cell Carcinoma with Immunohistochemical Characterization of Normal and Neoplastic Merkel Cells. Vet. Pathol. 2015;52:1012\u20131018. doi: 10.1177/0300985815570484.", "ArticleIdList": ["10.1177/0300985815570484", "25653203"]}, {"Citation": "Truong A.B., Kretz M., Ridky T.W., Kimmel R., Khavari P.A. P63 Regulates Proliferation and Differentiation of Developmentally Mature Keratinocytes. Genes Dev. 2006;20:3185\u20133197. doi: 10.1101/gad.1463206.", "ArticleIdList": ["10.1101/gad.1463206", "PMC1635152", "17114587"]}, {"Citation": "Nguyen B.C., Lefort K., Mandinova A., Antonini D., Devgan V., Della Gatta G., Koster M.I., Zhang Z., Wang J., Di Vignano A.T., et al. Cross-Regulation between Notch and P63 in Keratinocyte Commitment to Differentiation. Genes Dev. 2006;20:1028\u20131042. doi: 10.1101/gad.1406006.", "ArticleIdList": ["10.1101/gad.1406006", "PMC1472299", "16618808"]}, {"Citation": "Osada M., Nagakawa Y., Park H.L., Yamashita K., Wu G., Kim M.S., Fomenkov A., Trink B., Sidransky D. P63-Specific Activation of the BPAG-1e Promoter. J. Investig. Dermatol. 2005;125:52\u201360. doi: 10.1111/j.0022-202X.2005.23801.x.", "ArticleIdList": ["10.1111/j.0022-202X.2005.23801.x", "15982302"]}, {"Citation": "Ihrie R.A., Marques M.R., Nguyen B.T., Horner J.S., Papazoglu C., Bronson R.T., Mills A.A., Attardi L.D. Perp Is a P63-Regulated Gene Essential for Epithelial Integrity. Cell. 2005;120:843\u2013856. doi: 10.1016/j.cell.2005.01.008.", "ArticleIdList": ["10.1016/j.cell.2005.01.008", "15797384"]}, {"Citation": "Carroll D.K., Carroll J.S., Leong C.-O., Cheng F., Brown M., Mills A.A., Brugge J.S., Ellisen L.W. P63 Regulates an Adhesion Programme and Cell Survival in Epithelial Cells. Nat. Cell Biol. 2006;8:551\u2013561. doi: 10.1038/ncb1420.", "ArticleIdList": ["10.1038/ncb1420", "16715076"]}, {"Citation": "Shimomura Y., Wajid M., Shapiro L., Christiano A.M. P-Cadherin Is a P63 Target Gene with a Crucial Role in the Developing Human Limb Bud and Hair Follicle. Development. 2008;135:743\u2013753. doi: 10.1242/dev.006718.", "ArticleIdList": ["10.1242/dev.006718", "18199584"]}, {"Citation": "Koster M.I., Dai D., Marinari B., Sano Y., Costanzo A., Karin M., Roop D.R. P63 Induces Key Target Genes Required for Epidermal Morphogenesis. Proc. Natl. Acad. Sci. USA. 2007;104:3255\u20133260. doi: 10.1073/pnas.0611376104.", "ArticleIdList": ["10.1073/pnas.0611376104", "PMC1805532", "17360634"]}, {"Citation": "Amelio I., Melino G., Candi E. P63 Adjusts Sugar Taste of Epidermal Layers. J. Investig. Dermatol. 2017;137:1204\u20131206. doi: 10.1016/j.jid.2017.02.967.", "ArticleIdList": ["10.1016/j.jid.2017.02.967", "28395898"]}, {"Citation": "Viticchi\u00e8 G., Agostini M., Lena A.M., Mancini M., Zhou H., Zolla L., Dinsdale D., Saintigny G., Melino G., Candi E. P63 Supports Aerobic Respiration through Hexokinase II. Proc. Natl. Acad. Sci. USA. 2015;112:11577\u201311582. doi: 10.1073/pnas.1508871112.", "ArticleIdList": ["10.1073/pnas.1508871112", "PMC4577137", "26324887"]}, {"Citation": "Latina A., Viticchi\u00e8 G., Lena A.M., Piro M.C., Annicchiarico-Petruzzelli M., Melino G., Candi E. \u0394Np63 Targets Cytoglobin to Inhibit Oxidative Stress-Induced Apoptosis in Keratinocytes and Lung Cancer. Oncogene. 2016;35:1493\u20131503. doi: 10.1038/onc.2015.222.", "ArticleIdList": ["10.1038/onc.2015.222", "26096935"]}, {"Citation": "Ramsey M.R., He L., Forster N., Ory B., Ellisen L.W. Physical Association of HDAC1 and HDAC2 with P63 Mediates Transcriptional Repression and Tumor Maintenance in Squamous Cell Carcinoma. Cancer Res. 2011;71:4373\u20134379. doi: 10.1158/0008-5472.CAN-11-0046.", "ArticleIdList": ["10.1158/0008-5472.CAN-11-0046", "PMC3129427", "21527555"]}, {"Citation": "LeBoeuf M., Terrell A., Trivedi S., Sinha S., Epstein J.A., Olson E.N., Morrisey E.E., Millar S.E. Hdac1 and Hdac2 Act Redundantly to Control P63 and P53 Functions in Epidermal Progenitor Cells. Dev. Cell. 2010;19:807\u2013818. doi: 10.1016/j.devcel.2010.10.015.", "ArticleIdList": ["10.1016/j.devcel.2010.10.015", "PMC3003338", "21093383"]}, {"Citation": "Lin-Shiao E., Lan Y., Coradin M., Anderson A., Donahue G., Simpson C.L., Sen P., Saffie R., Busino L., Garcia B.A., et al. KMT2D Regulates P63 Target Enhancers to Coordinate Epithelial Homeostasis. Genes Dev. 2018;32:181\u2013193. doi: 10.1101/gad.306241.117.", "ArticleIdList": ["10.1101/gad.306241.117", "PMC5830930", "29440247"]}, {"Citation": "Sen G.L., Boxer L.D., Webster D.E., Bussat R.T., Qu K., Zarnegar B.J., Johnston D., Siprashvili Z., Khavari P.A. ZNF750 Is a P63 Target Gene That Induces KLF4 to Drive Terminal Epidermal Differentiation. Dev. Cell. 2012;22:669\u2013677. doi: 10.1016/j.devcel.2011.12.001.", "ArticleIdList": ["10.1016/j.devcel.2011.12.001", "PMC3306457", "22364861"]}, {"Citation": "Boxer L.D., Barajas B., Tao S., Zhang J., Khavari P.A. Znf750 Interacts with KLF4 and RCOR1, KDM1A, And CTBP1/2 Chromatin Regulators to Repress Epidermal Progenitor Genes and Induce Differentiation Genes. Genes Dev. 2014;28:2013\u20132026. doi: 10.1101/gad.246579.114.", "ArticleIdList": ["10.1101/gad.246579.114", "PMC4173152", "25228645"]}, {"Citation": "Fessing M.Y., Mardaryev A.N., Gdula M.R., Sharov A.A., Sharova T.Y., Rapisarda V., Gordon K.B., Smorodchenko A.D., Poterlowicz K., Ferone G., et al. P63 Regulates Satb1 to Control Tissue-Specific Chromatin Remodeling during Development of the Epidermis. J. Cell Biol. 2011;194:825\u2013839. doi: 10.1083/jcb.201101148.", "ArticleIdList": ["10.1083/jcb.201101148", "PMC3207288", "21930775"]}, {"Citation": "Mardaryev A.N., Gdula M.R., Yarker J.L., Emelianov V.N., Poterlowicz K., Sharov A.A., Sharova T.Y., Scarpa J.A., Chambon P., Botchkarev V.A., et al. P63 and Brg1 Control Developmentally Regulated Higher-Order Chromatin Remodelling at the Epidermal Differentiation Complex Locus in Epidermal Progenitor Cells. Development. 2014;141:101\u2013111. doi: 10.1242/dev.103200.", "ArticleIdList": ["10.1242/dev.103200", "PMC3865752", "24346698"]}, {"Citation": "Rubin A.J., Barajas B.C., Furlan-Magaril M., Lopez-Pajares V., Mumbach M.R., Howard I., Kim D.S., Boxer L.D., Cairns J., Spivakov M., et al. Lineage-Specific Dynamic and Pre-Established Enhancer\u2013Promoter Contacts Cooperate in Terminal Differentiation. Nat. Genet. 2017;49:1522. doi: 10.1038/ng.3935.", "ArticleIdList": ["10.1038/ng.3935", "PMC5715812", "28805829"]}, {"Citation": "Bao X., Rubin A.J., Qu K., Zhang J., Giresi P.G., Chang H.Y., Khavari P.A. A Novel ATAC-Seq Approach Reveals Lineage-Specific Reinforcement of the Open Chromatin Landscape via Cooperation between BAF and P63. Genome Biol. 2015;16:284. doi: 10.1186/s13059-015-0840-9.", "ArticleIdList": ["10.1186/s13059-015-0840-9", "PMC4699366", "26683334"]}, {"Citation": "Kouwenhoven E.N., Oti M., Niehues H., van Heeringen S.J., Schalkwijk J., Stunnenberg H.G., van Bokhoven H., Zhou H. Transcription Factor P63 Bookmarks and Regulates Dynamic Enhancers during Epidermal Differentiation. EMBO Rep. 2015;16:863\u2013878. doi: 10.15252/embr.201439941.", "ArticleIdList": ["10.15252/embr.201439941", "PMC4515125", "26034101"]}, {"Citation": "Smirnov A., Lena A.M., Cappello A., Panatta E., Anemona L., Bischetti S., Annicchiarico-Petruzzelli M., Mauriello A., Melino G., Candi E. ZNF185 Is a P63 Target Gene Critical for Epidermal Differentiation and Squamous Cell Carcinoma Development. Oncogene. 2018;38:1625. doi: 10.1038/s41388-018-0509-4.", "ArticleIdList": ["10.1038/s41388-018-0509-4", "PMC6755960", "30337687"]}, {"Citation": "Gatti V., Fierro C., Annicchiarico-Petruzzelli M., Melino G., Peschiaroli A. \u0394Np63 in Squamous Cell Carcinoma: Defining the Oncogenic Routes Affecting Epigenetic Landscape and Tumour Microenvironment. Mol. Oncol. 2019;13:981\u20131001. doi: 10.1002/1878-0261.12473.", "ArticleIdList": ["10.1002/1878-0261.12473", "PMC6487733", "30845357"]}, {"Citation": "Moses M.A., George A.L., Sakakibara N., Mahmood K., Ponnamperuma R.M., King K.E., Weinberg W.C. Molecular Mechanisms of P63-Mediated Squamous Cancer Pathogenesis. Int. J. Mol. Sci. 2019;20:3590. doi: 10.3390/ijms20143590.", "ArticleIdList": ["10.3390/ijms20143590", "PMC6678256", "31340447"]}, {"Citation": "Ha L., Ponnamperuma R.M., Jay S., Ricci M.S., Weinberg W.C. Dysregulated \u0394Np63\u03b1 Inhibits Expression of Ink4a/Arf, Blocks Senescence, and Promotes Malignant Conversion of Keratinocytes. PLoS ONE. 2011;6:e21877. doi: 10.1371/journal.pone.0021877.", "ArticleIdList": ["10.1371/journal.pone.0021877", "PMC3137598", "21789189"]}, {"Citation": "Keyes W.M., Pecoraro M., Aranda V., Vernersson-Lindahl E., Li W., Vogel H., Guo X., Garcia E.L., Michurina T.V., Enikolopov G., et al. \u0394np63\u03b1 Is an Oncogene That Targets Chromatin Remodeler Lsh to Drive Skin Stem Cell Proliferation and Tumorigenesis. Cell Stem Cell. 2011;8:164\u2013176. doi: 10.1016/j.stem.2010.12.009.", "ArticleIdList": ["10.1016/j.stem.2010.12.009", "PMC4373450", "21295273"]}, {"Citation": "Chikh A., Matin R.N.H., Senatore V., Hufbauer M., Lavery D., Raimondi C., Ostano P., Mello-Grand M., Ghimenti C., Bahta A., et al. IASPP/P63 Autoregulatory Feedback Loop Is Required for the Homeostasis of Stratified Epithelia. EMBO J. 2011;30:4261\u20134273. doi: 10.1038/emboj.2011.302.", "ArticleIdList": ["10.1038/emboj.2011.302", "PMC3199390", "21897369"]}, {"Citation": "Robinson D.J., Patel A., Purdie K.J., Wang J., Rizvi H., Hufbauer M., Ostano P., Akg\u00fcl B., Chiorino G., Harwood C.A., et al. Epigenetic Regulation of IASPP-P63 Feedback Loop in Cutaneous Squamous Cell Carcinoma. J. Investig. Dermatol. 2019;139:1658\u20131671. doi: 10.1016/j.jid.2019.01.020.", "ArticleIdList": ["10.1016/j.jid.2019.01.020", "30710576"]}, {"Citation": "Hazawa M., Lin D., Kobayashi A., Jiang Y., Xu L., Dewi F.R.P., Mohamed M.S., Hartono, Nakada M., Meguro-Horike M., et al. ROCK-dependent Phosphorylation of NUP 62 Regulates P63 Nuclear Transport and Squamous Cell Carcinoma Proliferation. EMBO Rep. 2018;19:73\u201388. doi: 10.15252/embr.201744523.", "ArticleIdList": ["10.15252/embr.201744523", "PMC5757218", "29217659"]}, {"Citation": "DeYoung M.P., Johannessen C.M., Leong C.O., Faquin W., Rocco J.W., Ellisen L.W. Tumor-Specific P73 up-Regulation Mediates P63 Dependence in Squamous Cell Carcinoma. Cancer Res. 2006;66:9362\u20139368. doi: 10.1158/0008-5472.CAN-06-1619.", "ArticleIdList": ["10.1158/0008-5472.CAN-06-1619", "17018588"]}, {"Citation": "Cordani N., Pozzi S., Martynova E., Fanoni D., Borrelli S., Alotto D., Castagnoli C., Berti E., Vigan\u00f2 M.A., Mantovani R. Mutant P53 Subverts P63 Control over KLF4 Expression in Keratinocytes. Oncogene. 2011;30:922. doi: 10.1038/onc.2010.474.", "ArticleIdList": ["10.1038/onc.2010.474", "20972454"]}, {"Citation": "Bornachea O., L\u00f3pez-Calder\u00f3n F.F., Due\u00f1as M., Segrelles C., Lorz C., Su\u00e1rez-Cabrera C., Mara\u00f1\u00f3n M., Paradela-Dobarro B., Santos M., Paramio J.M. The Downregulation of \u0394Np63 in P53-Deficient Mouse Epidermal Tumors Favors Metastatic Behavior. Oncotarget. 2015;6:24230. doi: 10.18632/oncotarget.4353.", "ArticleIdList": ["10.18632/oncotarget.4353", "PMC4695182", "26203771"]}, {"Citation": "Anna B., Blazej Z., Jacqueline G., Andrew C.J., Jeffrey R., Andrzej S. Mechanism of UV-Related Carcinogenesis and Its Contribution to Nevi/Melanoma. Expert Rev. Dermatol. 2007;2:451\u2013469.", "ArticleIdList": ["PMC2564815", "18846265"]}, {"Citation": "Gordon R. Skin Cancer: An Overview of Epidemiology and Risk Factors. Semin. Oncol. Nurs. 2013;29:160\u2013169. doi: 10.1016/j.soncn.2013.06.002.", "ArticleIdList": ["10.1016/j.soncn.2013.06.002", "23958214"]}, {"Citation": "Epstein E.H. Basal Cell Carcinomas: Attack of the Hedgehog. Nat. Rev. Cancer. 2008;8:743. doi: 10.1038/nrc2503.", "ArticleIdList": ["10.1038/nrc2503", "PMC4457317", "18813320"]}, {"Citation": "Peterson S.C., Eberl M., Vagnozzi A.N., Belkadi A., Veniaminova N.A., Verhaegen M.E., Bichakjian C.K., Ward N.L., Dlugosz A.A., Wong S.Y. Basal Cell Carcinoma Preferentially Arises from Stem Cells within Hair Follicle and Mechanosensory Niches. Cell Stem Cell. 2015;16:400\u2013412. doi: 10.1016/j.stem.2015.02.006.", "ArticleIdList": ["10.1016/j.stem.2015.02.006", "PMC4387376", "25842978"]}, {"Citation": "Takeuchi Y., Tamura A., Kamiya M., Fukuda T., Ishikawa O. Immunohistochemical Analyses of P63 Expression in Cutaneous Tumours. Br. J. Dermatol. 2005;153:1230\u20131232. doi: 10.1111/j.1365-2133.2005.06952.x.", "ArticleIdList": ["10.1111/j.1365-2133.2005.06952.x", "16307669"]}, {"Citation": "Park H.R., Soo K.M., Hyun D.C., Kwang H.K., Hyung S.S., Young E.P. Expression Profiles of P63, P53, Survivin, and HTERT in Skin Tumors. J. Cutan. Pathol. 2004;31:544\u2013549. doi: 10.1111/j.0303-6987.2004.00228.x.", "ArticleIdList": ["10.1111/j.0303-6987.2004.00228.x", "15268709"]}, {"Citation": "Bircan S., Candir O., Kapucoglu N., Baspinar S. The Expression of P63 in Basal Cell Carcinomas and Association with Histological Differentiation. J. Cutan. Pathol. 2006;33:293\u2013298. doi: 10.1111/j.0303-6987.2006.00436.x.", "ArticleIdList": ["10.1111/j.0303-6987.2006.00436.x", "16630179"]}, {"Citation": "Kanitakis J., Chouvet B. Expression of P63 in Cutaneous Metastases. Am. J. Clin. Pathol. 2007;128:753\u2013758. doi: 10.1309/BD3K8U7KD969Y07U.", "ArticleIdList": ["10.1309/BD3K8U7KD969Y07U", "17951196"]}, {"Citation": "Sakiz D., Turkmenoglu T.T., Kabukcuoglu F. The Expression of P63 and P53 in Keratoacanthoma and Intraepidermal and Invasive Neoplasms of the Skin. Pathol. Res. Pract. 2009;205:589\u2013594. doi: 10.1016/j.prp.2009.01.010.", "ArticleIdList": ["10.1016/j.prp.2009.01.010", "19577853"]}, {"Citation": "Burton K.A., Ashack K.A., Khachemoune A. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease. Am. J. Clin. Dermatol. 2016;17:491\u2013508. doi: 10.1007/s40257-016-0207-3.", "ArticleIdList": ["10.1007/s40257-016-0207-3", "27358187"]}, {"Citation": "Lapouge G., Youssef K.K., Vokaer B., Achouri Y., Michaux C., Sotiropoulou P.A., Blanpain C. Identifying the Cellular Origin of Squamous Skin Tumors. Proc. Natl. Acad. Sci. USA. 2011;108:7431\u20137436. doi: 10.1073/pnas.1012720108.", "ArticleIdList": ["10.1073/pnas.1012720108", "PMC3088632", "21502497"]}, {"Citation": "Abbas O., Richards J.E., Yaar R., Mahalingam M. Stem Cell Markers (Cytokeratin 15, Cytokeratin 19 and P63) in in Situ and Invasive Cutaneous Epithelial Lesions. Mod. Pathol. 2011;24:90. doi: 10.1038/modpathol.2010.180.", "ArticleIdList": ["10.1038/modpathol.2010.180", "20852595"]}, {"Citation": "Wrone D.A., Yoo S., Chipps L.K., Moy R.L. The Expression of P63 in Actinic Keratosis, Seborrheic Keratosis, and Cutaneous Squamous Cell Carcinomas. Dermatol. Surg. 2004;30:1299\u20131302.", "ArticleIdList": ["15458526"]}, {"Citation": "Cassarino D.S., DeRienzo D.P., Barr R.J. Cutaneous Squamous Cell Carcinoma: A Comprehensive Clinicopathologic Classification\u2014Part Two. J. Cutan. Pathol. 2006;33:261\u2013279. doi: 10.1111/j.0303-6987.2006.00516.x.", "ArticleIdList": ["10.1111/j.0303-6987.2006.00516.x", "16630176"]}, {"Citation": "Dotto J.E., Glusac E.J. P63 Is a Useful Marker for Cutaneous Spindle Cell Squamous Cell Carcinoma. J. Cutan. Pathol. 2006;33:413\u2013417. doi: 10.1111/j.0303-6987.2006.00477.x.", "ArticleIdList": ["10.1111/j.0303-6987.2006.00477.x", "16776716"]}, {"Citation": "Hall J.M., Saenger J.S., Fadare O. Diagnostic Utility of P63 and CD10 in Distinguishing Cutaneous Spindle Cell/Sarcomatoid Squamous Cell Carcinomas and Atypical Fibroxanthomas. Int. J. Clin. Exp. Pathol. 2008;1:524.", "ArticleIdList": ["PMC2480581", "18787630"]}, {"Citation": "Gleason B.C., Calder K.B., Cibull T.L., Thomas A.B., Billings S.D., Morgan M.B., Hiatt K.M., Smoller B.R. Utility of P63 in the Differential Diagnosis of Atypical Fibroxanthoma and Spindle Cell Squamous Cell Carcinoma. J. Cutan. Pathol. 2009;36:543\u2013547. doi: 10.1111/j.1600-0560.2008.01099.x.", "ArticleIdList": ["10.1111/j.1600-0560.2008.01099.x", "19476522"]}, {"Citation": "Kanner W.A., Brill L.B., Patterson J.W., Wick M.R. CD10, P63 and CD99 Expression in the Differential Diagnosis of Atypical Fibroxanthoma, Spindle Cell Squamous Cell Carcinoma and Desmoplastic Melanoma. J. Cutan. Pathol. 2010;37:744\u2013750. doi: 10.1111/j.1600-0560.2010.01534.x.", "ArticleIdList": ["10.1111/j.1600-0560.2010.01534.x", "20184665"]}, {"Citation": "Ko C.J., Leffell D.J., McNiff J.M. Adenosquamous Carcinoma: A Report of Nine Cases with P63 and Cytokeratin 5/6 Staining. J. Cutan. Pathol. 2009;36:448\u2013452. doi: 10.1111/j.1600-0560.2008.01083.x.", "ArticleIdList": ["10.1111/j.1600-0560.2008.01083.x", "19278431"]}, {"Citation": "Ko C.J., McNiff J.M., Glusac E.J. Squamous Cell Carcinomas with Single Cell Infiltration: A Potential Diagnostic Pitfall and the Utility of MNF116 and P63. J. Cutan. Pathol. 2008;35:353\u2013357. doi: 10.1111/j.1600-0560.2007.00808.x.", "ArticleIdList": ["10.1111/j.1600-0560.2007.00808.x", "18333895"]}, {"Citation": "Roh N.K., Hahn H.J., Lee Y.W., Choe Y.B., Ahn K.J. Clinical and Histopathological Investigation of Seborrheic Keratosis. Ann. Dermatol. 2016;28:152\u2013158. doi: 10.5021/ad.2016.28.2.152.", "ArticleIdList": ["10.5021/ad.2016.28.2.152", "PMC4828376", "27081260"]}, {"Citation": "Zargaran M., Baghaei F. A Clinical, Histopathological and Immunohistochemical Approach to the Bewildering Diagnosis of Keratoacanthoma. J. Dent. 2014;15:91.", "ArticleIdList": ["PMC4149899", "25191656"]}, {"Citation": "Sertznig P., von Felbert V., Megahed M. Porokeratosis: Present Concepts. J. Eur. Acad. Dermatol. Venereol. 2012;26:404\u2013412. doi: 10.1111/j.1468-3083.2011.04275.x.", "ArticleIdList": ["10.1111/j.1468-3083.2011.04275.x", "21929548"]}, {"Citation": "Roewert-Huber J., Stockfleth E., Kerl H. Pathology and Pathobiology of Actinic (Solar) Keratosis\u2014An Update. Br. J. Dermatol. 2007;157:18\u201320. doi: 10.1111/j.1365-2133.2007.08267.x.", "ArticleIdList": ["10.1111/j.1365-2133.2007.08267.x", "18067626"]}, {"Citation": "Neagu T.P., \u0162igli\u015f M., Botezatu D., Enache V., Cobilinschi C.O., V\u00e2lcea-Precup M.S., Grin\u0163escu I.M. Clinical, Histological and Therapeutic Features of Bowen\u2019s Disease. Rom. J. Morphol. Embryol. 2017;58:33\u201340.", "ArticleIdList": ["28523295"]}, {"Citation": "Dubina M., Goldenberg G. Viral-Associated Nonmelanoma Skin Cancers: A Review. Am. J. Dermatopathol. 2009;31:561\u2013573. doi: 10.1097/DAD.0b013e3181a58234.", "ArticleIdList": ["10.1097/DAD.0b013e3181a58234", "19590418"]}, {"Citation": "Ha Lan T.T., Chen S.J.T., Arps D.P., Fullen D.R., Patel R.M., Siddiqui J., Carskadon S., Palanisamy N., Harms P.W. Expression of the P40 Isoform of P63 Has High Specificity for Cutaneous Sarcomatoid Squamous Cell Carcinoma. J. Cutan. Pathol. 2014;41:831\u2013838. doi: 10.1111/cup.12387.", "ArticleIdList": ["10.1111/cup.12387", "25263756"]}, {"Citation": "Mai R., Zhou S., Zhou S., Zhong W., Hong L., Wang Y., Lu S., Pan J., Huang Y., Su M., et al. Transcriptome Analyses Reveal FOXA1 Dysregulation in Mammary and Extramammary Paget\u2019s Disease. Hum. Pathol. 2018;77:152\u2013158. doi: 10.1016/j.humpath.2017.12.030.", "ArticleIdList": ["10.1016/j.humpath.2017.12.030", "29630912"]}, {"Citation": "Leonardi G.C., Falzone L., Salemi R., Zangh\u00ec A., Spandidos D.A., Mccubrey J.A., Candido S., Libra M. Cutaneous Melanoma: From Pathogenesis to Therapy. Int. J. Oncol. 2018;52:1071\u20131080. doi: 10.3892/ijo.2018.4287.", "ArticleIdList": ["10.3892/ijo.2018.4287", "PMC5843392", "29532857"]}, {"Citation": "Shain A.H., Bastian B.C. From Melanocytes to Melanomas. Nat. Rev. Cancer. 2016;16:345. doi: 10.1038/nrc.2016.37.", "ArticleIdList": ["10.1038/nrc.2016.37", "27125352"]}, {"Citation": "Brinck U., Ruschenburg I., Di Como C.J., Buschmann N., Betke H., Stachura J., Cordon-Cardo C., Korabiowska M. Comparative Study of P63 and P53 Expression in Tissue Microarrays of Malignant Melanomas. Int. J. Mol. Med. 2002;10:707\u2013711. doi: 10.3892/ijmm.10.6.707.", "ArticleIdList": ["10.3892/ijmm.10.6.707", "12429996"]}, {"Citation": "Reis-Filho J.S., Simpson P.T., Martins A., Preto A., G\u00e4rtner F., Schmitt F.C. Distribution of P63, Cytokeratins 5/6 and Cytokeratin 14 in 51 Normal and 400 Neoplastic Human Tissue Samples Using TARP-4 Multi-Tumor Tissue Microarray. Virchows Arch. 2003;443:122\u2013132.", "ArticleIdList": ["12884041"]}, {"Citation": "Bourne T.D., Bellizzi A.M., Stelow E.B., Loy A.H., Levine P.A., Wick M.R., Mills S.E. P63 Expression in Olfactory Neuroblastoma and Other Small Cell Tumors of the Sinonasal Tract. Am. J. Clin. Pathol. 2008;130:213\u2013218. doi: 10.1309/TEDD2FCWH8W0H4HA.", "ArticleIdList": ["10.1309/TEDD2FCWH8W0H4HA", "18628089"]}, {"Citation": "Monti P., Ghiorzo P., Menichini P., Foggetti G., Queirolo P., Izzotti A., Fronza G. TP63 Mutations are Frequent in Cutaneous Melanoma, Support UV Etiology, but Their Role in Melanomagenesis is Unclear. Oncol. Rep. 2017;38:1985\u20131994. doi: 10.3892/or.2017.5903.", "ArticleIdList": ["10.3892/or.2017.5903", "PMC5652947", "28849221"]}, {"Citation": "Browne G., Cipollone R., Lena A.M., Serra V., Zhou H., van Bokhoven H., D\u00f6tsch V., Merico D., Mantovani R., Terrinoni A., et al. Differential Altered Stability and Transcriptional Activity of \u0394Np63 Mutants in Distinct Ectodermal Dysplasias. J. Cell Sci. 2011;124:2200\u20132207. doi: 10.1242/jcs.079327.", "ArticleIdList": ["10.1242/jcs.079327", "21652629"]}, {"Citation": "Epstein J.I., Egevad L., Humphrey P.A., Montironi R., Amin M.B., Ulbright T.M., Grignon D., Trpkov K., Lopez-Beltran A., Zhou M., et al. Best Practices Recommendations in the Application of Immunohistochemistry in the Prostate: Report from the International Society of Urologic Pathology Consensus Conference. Am. J. Surg. Pathol. 2014;38:e6\u2013e19. doi: 10.1097/PAS.0000000000000238.", "ArticleIdList": ["10.1097/PAS.0000000000000238", "25029122"]}, {"Citation": "Amin M.B., Epstein J.I., Ulbright T.M., Humphrey P.A., Egevad L., Montironi R., Grignon D., Trpkov K., Lopez-Beltran A., Zhou M., et al. Best Practices Recommendations in the Application of Immunohistochemistry in Urologic Pathology: Report from the International Society of Urological Pathology Consensus Conference. Am. J. Surg. Pathol. 2014;38:1017\u20131022. doi: 10.1097/PAS.0000000000000254.", "ArticleIdList": ["10.1097/PAS.0000000000000254", "25025364"]}, {"Citation": "Travis W.D., Brambilla E., Noguchi M., Nicholson A.G., Geisinger K., Yatabe Y., Powell C.A., Beer D., Riely G., Garg K., et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: International Multidisciplinary Classification of Lung Adenocarcinoma\u2014An Executive Summary. Proc. Am. Thorac. Soc. 2011;6:244\u2013285. doi: 10.1097/JTO.0b013e318206a221.", "ArticleIdList": ["10.1097/JTO.0b013e318206a221", "21926387"]}, {"Citation": "Mehregan A.H. The Origin of the Adnexal Tumors of the Skin: A Viewpoint. J. Cutan. Pathol. 1985;12:459\u2013467. doi: 10.1111/j.1600-0560.1985.tb00444.x.", "ArticleIdList": ["10.1111/j.1600-0560.1985.tb00444.x", "4078108"]}, {"Citation": "Agrawal S., Jain R., Panchonia A., Kulkarni C., Mehar R. \u201cTroublesome Tumors\u201d of the Skin: Spectrum of Skin Adnexal Tumors at a Tertiary Care Center in Malwa Region. Int. J. Med. Sci. Public Health. 2018;7:714\u2013719. doi: 10.5455/ijmsph.2018.0308801062018.", "ArticleIdList": ["10.5455/ijmsph.2018.0308801062018"]}, {"Citation": "Fulton E.H., Kaley J.R., Gardner J.M. Skin Adnexal Tumors in Plain Language a Practical Approach for the General Surgical Pathologist. Arch. Pathol. Lab. Med. 2019;143:832\u2013851. doi: 10.5858/arpa.2018-0189-RA.", "ArticleIdList": ["10.5858/arpa.2018-0189-RA", "30638401"]}, {"Citation": "Qureshi H.S., Ormsby A.H., Lee M.W., Zarbo R.J., Ma C.K. The Diagnostic Utility of P63, CK5/6, CK 7, and CK 20 in Distinguishing Primary Cutaneous Adnexal Neoplasms from Metastatic Carcinomas. J. Cutan. Pathol. 2004;31:145\u2013152. doi: 10.1111/j.0303-6987.2004.00147.x.", "ArticleIdList": ["10.1111/j.0303-6987.2004.00147.x", "14690459"]}, {"Citation": "Qureshi H.S., Salama M.E., Chitale D., Bansal I., Ma C.K., Raju U., Ormsby A., Lee M.W. Primary Cutaneous Mucinous Carcinoma: Presence of Myoepithelial Cells as a Clue to the Cutaneous Origin. Am. J. Dermatopathol. 2004;26:353\u2013358. doi: 10.1097/00000372-200410000-00001.", "ArticleIdList": ["10.1097/00000372-200410000-00001", "15365364"]}, {"Citation": "Ivan D., Diwan A.H., Prieto V.G. Expression of P63 in Primary Cutaneous Adnexal Neoplasms and Adenocarcinoma Metastatic to the Skin. J. Cutan. Pathol. 2005;32:94. doi: 10.1111/j.0303-6987.2005.320cz.x.", "ArticleIdList": ["10.1111/j.0303-6987.2005.320cz.x", "15389254"]}, {"Citation": "Ivan D., Nash J.W., Prieto V.G., Calonje E., Lyle S., Diwan A.H., Lazar A.J.F. Use of P63 Expression in Distinguishing Primary and Metastatic Cutaneous Adnexal Neoplasms from Metastatic Adenocarcinoma to Skin. J. Cutan. Pathol. 2007;34:474\u2013480. doi: 10.1111/j.1600-0560.2006.00644.x.", "ArticleIdList": ["10.1111/j.1600-0560.2006.00644.x", "17518775"]}, {"Citation": "Valencia-Guerrero A., Dresser K., Cornejo K.M. Utility of Immunohistochemistry in Distinguishing Primary Adnexal Carcinoma from Metastatic Breast Carcinoma to Skin and Squamous Cell Carcinoma. Am. J. Dermatopathol. 2018;40:389\u2013396. doi: 10.1097/DAD.0000000000001025.", "ArticleIdList": ["10.1097/DAD.0000000000001025", "29781860"]}, {"Citation": "Panse G., Cowper S.E., Leffell D.J., Pulitzer M., Ko C.J. Well-Differentiated Neuroendocrine Tumors in Skin: Terminology and Diagnostic Utility of Cytokeratin 5/6 and P63. J. Cutan. Pathol. 2017;44:557\u2013562. doi: 10.1111/cup.12952.", "ArticleIdList": ["10.1111/cup.12952", "28417484"]}, {"Citation": "Chapman L.W., Yu S.S., Arron S.T. Atypical Fibroxanthoma. Semin. Cutan. Med. Surg. 2019;38:E65\u2013E66. doi: 10.12788/j.sder.2019.008.", "ArticleIdList": ["10.12788/j.sder.2019.008", "31051027"]}, {"Citation": "Koch M., Freundl A.J., Agaimy A., Kiesewetter F., K\u00fcnzel J., Cicha I., Alexiou C. Atypical Fibroxanthoma-Histological Diagnosis, Immunohistochemical Markers and Concepts of Therapy. Anticancer Res. 2015;35:5717\u20135735.", "ArticleIdList": ["26503993"]}, {"Citation": "Morgan M.B., Purohit C., Anglin T.R. Immunohistochemical Distinction of Cutaneous Spindle Cell Carcinoma. Am. J. Dermatopathol. 2008;30:228\u2013232. doi: 10.1097/DAD.0b013e31816de820.", "ArticleIdList": ["10.1097/DAD.0b013e31816de820", "18496422"]}, {"Citation": "Buonaccorsi J.N., Plaza J.A. Role of CD10, Wide-Spectrum Keratin, P63, and Podoplanin in the Distinction of Epithelioid and Spindle Cell Tumors of the Skin: An Immunohistochemical Study of 81 Cases. Am. J. Dermatopathol. 2012;34:404\u2013411. doi: 10.1097/DAD.0b013e318236b17f.", "ArticleIdList": ["10.1097/DAD.0b013e318236b17f", "22257901"]}, {"Citation": "Henderson S.A., Torres-Cabala C.A., Curry J.L., Bassett R.L., Ivan D., Prieto V.G., Tetzlaff M.T. P40 Is More Specific than P63 for the Distinction of Atypical Fibroxanthoma from Other Cutaneous Spindle Cell Malignancies. Am. J. Surg. Pathol. 2014;38:1102\u20131110. doi: 10.1097/PAS.0000000000000245.", "ArticleIdList": ["10.1097/PAS.0000000000000245", "25029117"]}, {"Citation": "Alomari A.K., Glusac E.J., McNiff J.M. P40 Is a More Specific Marker than P63 for Cutaneous Poorly Differentiated Squamous Cell Carcinoma. J. Cutan. Pathol. 2014;41:839\u2013845. doi: 10.1111/cup.12388.", "ArticleIdList": ["10.1111/cup.12388", "25263848"]}, {"Citation": "Becker J.C., Stang A., DeCaprio J.A., Cerroni L., Lebb\u00e9 C., Veness M., Nghiem P. Merkel Cell Carcinoma. Nat. Rev. Dis. Primer. 2017;3:17077. doi: 10.1038/nrdp.2017.77.", "ArticleIdList": ["10.1038/nrdp.2017.77", "PMC6054450", "29072302"]}, {"Citation": "Asioli S., Righi A., Volante M., Eusebi V., Bussolati G. P63 Expression as a New Prognostic Marker in Mrkel Cell Carcinoma. Cancer. 2007;110:640\u2013647. doi: 10.1002/cncr.22828.", "ArticleIdList": ["10.1002/cncr.22828", "17599745"]}, {"Citation": "Asioli S., Righi A., De Biase D., Morandi L., Caliendo V., Picciotto F., MacRip\u00f2 G., Maletta F., Di Cantogno L.V., Chiusa L., et al. Expression of P63 Is the Sole Independent Marker of Aggressiveness in Localised (Stage I\u2013II) Merkel Cell Carcinomas. Mod. Pathol. 2011;24:1451. doi: 10.1038/modpathol.2011.100.", "ArticleIdList": ["10.1038/modpathol.2011.100", "21765392"]}, {"Citation": "Hall B.J., Pincus L.B., Yu S.S., Oh D.H., Wilson A.R., McCalmont T.H. Immunohistochemical Prognostication of Merkel Cell Carcinoma: P63 Expression but Not Polyomavirus Status Correlates with Outcome. J. Cutan. Pathol. 2012;39:911\u2013917. doi: 10.1111/j.1600-0560.2012.01964.x.", "ArticleIdList": ["10.1111/j.1600-0560.2012.01964.x", "22882157"]}, {"Citation": "Stetsenko G.Y., Malekirad J., Paulson K.G., Iyer J.G., Thibodeau R.M., Nagase K., Schmidt M., Storer B.E., Argenyi Z.B., Nghiem P. P63 Expression in Merkel Cell Carcinoma Predicts Poorer Survival yet May Have Limited Clinical Utility. Am. J. Clin. Pathol. 2013;140:838\u2013844. doi: 10.1309/AJCPE4PK6CTBNQJY.", "ArticleIdList": ["10.1309/AJCPE4PK6CTBNQJY", "PMC4074520", "24225752"]}, {"Citation": "Fleming K.E., Ly T.Y., Pasternak S., Godlewski M., Doucette S., Walsh N.M. Support for P63 Expression as an Adverse Prognostic Marker in Merkel Cell Carcinoma: Report on a Canadian Cohort. Hum. Pathol. 2014;45:952\u2013960. doi: 10.1016/j.humpath.2013.12.008.", "ArticleIdList": ["10.1016/j.humpath.2013.12.008", "24746200"]}, {"Citation": "Lim C.S., Whalley D., Haydu L.E., Murali R., Tippett J., Thompson J.F., Hruby G., Scolyer R.A. Increasing Tumor Thickness Is Associated with Recurrence and Poorer Survival in Patients with Merkel Cell Carcinoma. Ann. Surg. Oncol. 2012;19:3325\u20133334. doi: 10.1245/s10434-012-2509-x.", "ArticleIdList": ["10.1245/s10434-012-2509-x", "22820936"]}, {"Citation": "Dabner M., McClure R.J., Harvey N.T., Budgeon C.A., Beer T.W., Amanuel B., Wood B.A. Merkel Cell Polyomavirus and P63 Status in Merkel Cell Carcinoma by Immunohistochemistry: Merkel Cell Polyomavirus Positivity Is Inversely Correlated with Sun Damage, but Neither Is Correlated with Outcome. Pathology. 2014;46:205\u2013210. doi: 10.1097/PAT.0000000000000069.", "ArticleIdList": ["10.1097/PAT.0000000000000069", "24614722"]}, {"Citation": "Senoo M., Tsuchiya I., Matsumura Y., Mori T., Saito Y., Kato H., Okamoto T., Habu S. Transcriptional Dysregulation of the P73L/P63/P51/P40/KET Gene in Human Squamous Cell Carcinomas: Expression of \u0394Np73L, a Novel Dominant-Negative Isoform, and Loss of Expression of the Potential Tumour Suppressor P51. Br. J. Cancer. 2001;84:1235. doi: 10.1054/bjoc.2000.1735.", "ArticleIdList": ["10.1054/bjoc.2000.1735", "PMC2363892", "11336476"]}, {"Citation": "Geddert H., Kiel S., Heep H.J., Gabbert H.E., Sarbia M. The Role of P63 and \u0394Np63 (P40) Protein Expression and Gene Amplification in Esophageal Carcinogenesis. Hum. Pathol. 2003;34:850\u2013856. doi: 10.1016/S0046-8177(03)00342-3.", "ArticleIdList": ["10.1016/S0046-8177(03)00342-3", "14562279"]}, {"Citation": "Bishop J.A., Teruya-Feldstein J., Westra W.H., Pelosi G., Travis W.D., Rekhtman N. P40 (\u0394Np63) Is Superior to P63 for the Diagnosis of Pulmonary Squamous Cell Carcinoma. Mod. Pathol. 2012;25:405. doi: 10.1038/modpathol.2011.173.", "ArticleIdList": ["10.1038/modpathol.2011.173", "22056955"]}, {"Citation": "Nekulova M., Holcakova J., Nenutil R., Stratmann R., Bouchalova P., M\u00fcller P., Moukov\u00e1 L., Coates P.J., Vojtesek B. Characterization of Specific P63 and P63-N-Terminal Isoform Antibodies and Their Application for Immunohistochemistry. Virchows Arch. 2013;463:415\u2013425. doi: 10.1007/s00428-013-1459-4.", "ArticleIdList": ["10.1007/s00428-013-1459-4", "23887585"]}, {"Citation": "Lee J.J., Mochel M.C., Piris A., Boussahmain C., Mahalingam M., Hoang M.P. P40 Exhibits Better Specificity than P63 in Distinguishing Primary Skin Adnexal Carcinomas from Cutaneous Metastases. Hum. Pathol. 2014;45:1078\u20131083. doi: 10.1016/j.humpath.2014.01.006.", "ArticleIdList": ["10.1016/j.humpath.2014.01.006", "24746214"]}, {"Citation": "Andruszkow J.H.K., Oll M., F\u00f6rster S., Kn\u00fcchel R., J\u00e4kel J. P40 in Conjunction with CK20 and E-Cadherin Distinguishes Primary Adnexal Neoplasms of the Skin. Appl. Immunohistochem. Mol. Morphol. 2016;24:414\u2013421. doi: 10.1097/PAI.0000000000000204.", "ArticleIdList": ["10.1097/PAI.0000000000000204", "26180934"]}, {"Citation": "Jain D., Mathur S.R., Sharma M.C., Iyer V.K. Cytomorphology of Sebaceous Carcinoma with Analysis of P40 Antibody Expression. Diagn. Cytopathol. 2015;43:456\u2013461. doi: 10.1002/dc.23250.", "ArticleIdList": ["10.1002/dc.23250", "25611456"]}, {"Citation": "Kriegsmann K., Cremer M., Zgorzelski C., Harms A., Muley T., Winter H., Kazdal D., Warth A., Kriegsmann M. Agreement of CK5/6, P40, and P63 Immunoreactivity in Non-Small Cell Lung Cancer. Pathology. 2019;51:240\u2013245. doi: 10.1016/j.pathol.2018.11.009.", "ArticleIdList": ["10.1016/j.pathol.2018.11.009", "30798982"]}, {"Citation": "Tacha D., Bremer R., Haas T., Qi W. An Immunohistochemical Analysis of a Newly Developed, Mouse Monoclonal P40 (BC28) Antibody in Lung, Bladder, Skin, Breast, Prostate, and Head and Neck Cancers. Arch. Pathol. Lab. Med. 2014;138:1358\u20131364. doi: 10.5858/arpa.2013-0342-OA.", "ArticleIdList": ["10.5858/arpa.2013-0342-OA", "24528495"]}]}], "History": [{"Year": "2019", "Month": "10", "Day": "9"}, {"Year": "2019", "Month": "11", "Day": "7"}, {"Year": "2019", "Month": "11", "Day": "15"}, {"Year": "2019", "Month": "11", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31744230", "PMC6888618", "10.3390/ijms20225781", "ijms20225781"]}}]}